All In MedTech

Device type · GWJ

Stimulator, Auditory, Evoked Response

FDA groups similar devices under a three-letter product code. This page gathers what FDA's public data says about GWJ: how it is classified, what has been cleared or approved, and what has been reported and recalled.

Last checked: Nov 19, 2026Source: openFDAMethods & limitations

Product code

GWJ

Neurology

Device class

Class II

FDA decisions since 2015

8

510(k), De Novo and PMA

Adverse event reports

4

Received Nov 1, 2025 to Nov 19, 2026

How FDA classifies it

Device type
Stimulator, Auditory, Evoked Response
Product code
GWJ
Device class
Class II
Review panel
Neurology
Regulation
21 CFR 882.1900

Latest FDA decisions

All decisions for GWJ

5 more FDA decisions with a free account

Reports received

4

Received Nov 1, 2025 to Nov 19, 2026

Malfunction reports

4

100% of reports

Injury reports

0

0.0% of reports

Death reports

0

0.0% of reports

Adverse event reports received per month

By the date FDA received each report, stacked by event type. The newest month is incomplete.

Open in the MAUDE Monitor
  • Malfunction
  • Injury
  • Death
  • Other
View as table
MonthMalfunctionInjuryDeathOther
Dec 230000
Jan 240000
Feb 242000
Mar 240000
Apr 241000
May 240000
Jun 241000
Jul 242000
Aug 240000
Sep 240000
Oct 241000
Nov 240000
Dec 240000
Jan 250000
Feb 250000
Mar 251000
Apr 250000
May 250000
Jun 250000
Jul 250000
Aug 250000
Sep 250000
Oct 250000
Nov 250000
Dec 250000
Jan 260000
Feb 261000
Mar 262000
Apr 260000
May 260000
Jun 261000
Jul 260000
Aug 260000
Sep 260000
Oct 260000
Nov 260000

Manufacturers named most often

Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.

Device problems as coded

Last 12 months. FDA's terms. A report can carry several.

  • Sparking4
  • Electrical /Electronic Property Problem3

Patient problems as coded

Last 12 months. FDA's terms. A report can carry several.

  • No Clinical Signs, Symptoms or Conditions4

Recent recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

  • PATH

    Z-0940-2026 · Started Nov 6, 2025 · Posted by FDA Dec 18, 2025

    Reason given: Following a component change in the DPOAE probe (speaker replacement), technical distortions may occur at high stimulus levels combined with unusually low OAE amplitude acceptance thresholds. These distortions can mimic true DPOAE responses and may result in a false PASS outcome.

    Cause as FDA categorized it: Component change control

  • GN Otometrics

    Z-0170-2020 · Started May 28, 2019

    Reason given: There is a risk to the healthcare professional or patient of exposure to undergrounded electrical surfaces which may result in an electrical shock.

    Cause as FDA categorized it: Device Design

  • Natus Medical Inc

    Z-2165-2010 · Started Jun 4, 2010 · Posted by FDA Aug 3, 2010

    Reason given: There is insufficient evidence to support any claims for safety and efficacy on the SonaMed Clarity devices.

    Cause as FDA categorized it: PMA

1 more recall records with a free account

Back to all tools

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.